Arcutis Biotherapeutics has appointed Chris Peetz to its Board of Directors as of July 15, 2026. Peetz brings extensive experience leading biopharmaceutical companies through growth phases, product development, and strategic acquisitions. His addition is expected to support Arcutis' strategy to grow its ZORYVE franchise and expand its pipeline in immuno-dermatology. Peetz currently leads Mirum Pharmaceuticals and has a strong background in finance and corporate development within the biotech sector.
Empery Digital sold 1,635 Bitcoin for $102.2 million between July 1 and August 6, 2026, reducing its total holdings to 1,279 BTC with only 325 BTC unrestricted after pledging 954 BTC against $35 million debt. This marks a 76% drop in unrestricted Bit...
On August 8, Bitcoin perpetual futures trading volume on Binance dropped to its sixth-lowest daily level in five years, signaling a rare quiet period on the world's largest crypto derivatives exchange. This slowdown occurred even as Bitcoin's price r...
Veteran trader Peter Brandt suggests Bitcoin may face a decline based on a head-and-shoulders chart pattern formed between April and June 2026. The pattern shows Bitcoin's price peaking near $82,000 in May before breaking below a key $75,000 neckline...
Pump.fun, a Solana memecoin launchpad, will unlock 6.875 billion PUMP tokens on August 12, 2026, split between the development team and early investors. This unlock follows a larger July event releasing 82.5 billion tokens, raising concerns about sel...
AppLovin reported a 53% year-over-year revenue increase in Q2, maintaining over 75% profit margins, highlighting its rare combination of scale, profitability, and growth. The slight slowdown in sequential growth was due to timing of machine-learning ...
